July 2026 Edition
About the Newsletter
Each edition draws from RegulatoryID, MedPro's expert-maintained reference covering transparency and compliance requirements across 50+ countries. The team that maintains the compendium also curates each newsletter, surfacing the deadlines, filings and rule changes most relevant to Life Sciences manufacturers, distributors and medical device companies in the month ahead.
What You Receive Each Month
A single monthly newsletter delivered the first Tuesday of each month, covering U.S. and international jurisdictions
Concise high-level summaries in the email so you can quickly scan deadlines and what's required
Linked detailed summaries with full regulatory context, deadlines and reference links
Immediate alerts for urgent developments that cannot wait for the next monthly send
Inside the July Edition
Three filing windows opening between July 1 and July 31 across international jurisdictions, plus a preview of the upcoming CMS Open Payments release. Subscribe to access the full requirements, source links and submission detail for each.
CMS Open Payments Data for PY 2025 Coming 7/14
CMS is expected to release Program Year 2025 Open Payments data on July 1. Given the significance of this annual publication, we will share a dedicated summary with key insights and highlights following this monthly release.
South Korea Disclosures Due Between 7/1-7/20
Persons with product approval of pharmaceuticals, importers, pharmaceutical wholesalers, or pharmaceutical sales promoters entrusted by persons with product approval of pharmaceuticals, importers and pharmaceutical wholesalers must prepare an expenditure report on the details of economic benefits, etc. provided to pharmacists, herbal pharmacists, medical professionals, founders of medical institutions or employees of medical institutions or employees of medical institutions within three months after the end of each fiscal year and disclose the expenditure report as a part of the annual fact-finding survey under the Pharmaceutical Affairs Act (PAA).
A medical device manufacturer, importer, seller or lessor, or a medical device sales promotion business operator entrusted with medical devices sales or lease promotion duties by a manufacturer, importer, seller or lessor must prepare an expenditure report on the details of economic benefits, etc. provided to medical professionals, founders of medical institutions or employees of medical institutions within three months after the end of each fiscal year and disclose the expenditure report as a part of the annual fact-finding survey under the Medical Devices Act (MDA).
Philippines Biannual Disclosures Due 7/15
Under Administrative Order (AO) 2021-0036, all FDA-licensed manufacturers, traders, repackers and distributor-importers and distributor-wholesalers of FDA-registered drugs, medical devices and biological products, including vaccines and medical supplies, must bi-annually declare all financial relationships directly or indirectly made with healthcare professionals (HCPs) or healthcare providers, without limitation of value, to the Philippines Food and Drug Administration (FDA) via their central platform, Online Disclosure Report System (ODRS) by July 15 for the first half of the year.
Slovakia Biannual Pharmaceutical Disclosures Due 7/31
Pharmaceutical companies, licensed pharmaceutical care providers, holders of a registration for a human medicinal product, and holders of authorizations for manufacturing of medicinal products or wholesale distribution of medicinal products, must disclose all expenditures on promotion, marketing and monetary and non-monetary benefits granted directly or indirectly to healthcare professionals (HCPs) and healthcare providers to the Slovakian Ministry of Health by the biannual deadline of July 31 via Information System of Health Indicators (ISZI) or web services run by the National Centre for Health Information (NCZI).
Subscribe to the RegulatoryID Newsletter
Enter your work email to request access to the full July 2026 edition and to receive ongoing updates direct to your inbox.